Floatz logo

849 assets in Breast Cancer

Therapeutic assets addressing Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Xmt-2056
Breast Cancer
Day One Biopharmaceuticals, Inc.P1CC (43)
Zelenectide Pavedotin
Breast Cancer
BicycleTx LimitedP2CC (43)
Asidna
Breast Cancer
Valerio TherapeuticsP1/2CC (42)
Belinostat
Breast Cancer
University of UtahP1CC (42)
BMS986310
Breast Cancer
Ono Pharmaceutical Co., Ltd.P1CC (42)
Cilostazol
Breast Cancer
Mansoura UniversityP1/2CC (42)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-Oh (Ls301)
Breast Cancer
Integro TheranosticsP1/2CC (42)
e-602
Breast Cancer
Palleon Pharmaceuticals, Inc.P1/2CC (42)
H-Gamma1 Heavy Chain Homo Sapiens (1-447) [Vh (Homo Sapiens Ighv4-59*01 (99.0%) -(Ighd) -Ighj3*02 (93.3%) T125>I (114), Cdr-Imgt [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, 9-G1V21 Ch2 Y15.1, T16, E18 (Ch1 K120 (214) (118-215), Hinge 1-15 (216-230), Ch2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), Ch3 D12 (356), L14 (358) (341-445), Chs (446-447)) (118-447)], (220-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv3-11*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (Ckappa A45.1 (153'), V101 (191')) (108'-214')]; Dimer (226-226'':229-229'')-Bisdisulfide, Produced In A Cell Line Derived From Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa
Breast Cancer
Kineta Inc.P1/2CC (42)
Capmatinib
Breast Cancer
M.D. Anderson Cancer CenterP1/2CC (41)
CF33-expressing hNIS
Breast Cancer
City of Hope Medical CenterP1CC (41)
Immunoglobulin G1, Anti-(Human Neuregulin Receptor Her3) (Human Monoclonal U3-1287 Heavy Chain), Disulfide With Human Monoclonal U3-1287 ?-Chain, Dimer
Breast Cancer
Daiichi SankyoP2CC (41)
Iohexol
Breast Cancer
Alison StopeckP1CC (41)
Nelitolimod
Breast Cancer
QuantumLeap Healthcare CollaborativeP2CC (41)
Onapristone
Breast Cancer
Context Therapeutics Inc.P1/2CC (41)
Oncolytic Measles Virus Encoding Helicobacter Pylori Neutrophil-Activating Protein
Breast Cancer
Mayo ClinicP1CC (41)
Transferrin Receptor-Targeted Liposomal P53 Cdna
Breast Cancer
Northwestern UniversityP1CC (41)
[111in]-fpi-1967
Breast Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
[18f]f-resca-rb14
Breast Cancer
RenJi HospitalP1/2CC (40)
[18f]f-resca-rt4
Breast Cancer
RenJi HospitalP1/2CC (40)
[225Ac]-FPI-1966
Breast Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
4scar t cells
Breast Cancer
Shenzhen Geno-Immune Medical InstituteP1/2CC (40)
Ace-86225106
Breast Cancer
Acerand Therapeutics (Shanghai) LimitedP1/2CC (40)
ak138d1
Breast Cancer
AkesoP1/2CC (40)
Amxi-5001
Breast Cancer
AtlasMedx, IncorporatedP1/2CC (40)
Amxt1501
Breast Cancer
Aminex Therapeutics, Inc.P1/2CC (40)
Anti-Hcd70 Car Transduced Pbl
Breast Cancer
National Cancer Institute (NCI)P1/2CC (40)
Avutometinib
Breast Cancer
Adrienne G. WaksP1/2CC (40)
bc1 cell line
Breast Cancer
BriaCell Therapeutics CorporationP1/2CC (40)
Camonsertib
Breast Cancer
Canadian Cancer Trials GroupP2CC (40)
cl4
Breast Cancer
Fudan UniversityP1/2CC (40)
Dermaprazole 2%
Breast Cancer
Baylor College of MedicineP1/2CC (40)
Dual-Target Antigen-Selected Car-Nk
Breast Cancer
Essen BiotechP1/2CC (40)
Eb-Select Single-Target Car-Nk Cells
Breast Cancer
Essen BiotechP1/2CC (40)
Eflornithine
Breast Cancer
Aminex Therapeutics, Inc.P1/2CC (40)
Env-501
Breast Cancer
Hummingbird BioscienceP1/2CC (40)
Epidiferphane
Breast Cancer
University of FloridaP1/2CC (40)
Etx-19477
Breast Cancer
858 Therapeutics, Inc.P1/2CC (40)
Gdc-4198
Breast Cancer
Genentech, Inc.P1/2CC (40)
gm103
Breast Cancer
GeneMedicine Co., Ltd.P1/2CC (40)
her2 fpbmc
Breast Cancer
University of VirginiaP1/2CC (40)
Icasp9M28Z T Cell Infusions
Breast Cancer
Memorial Sloan Kettering Cancer CenterP1/2CC (40)
INX315
Breast Cancer
Incyclix BioP1/2CC (40)
Lisaftoclax
Breast Cancer
Ascentage Pharma Group Inc.P1/2CC (40)
Lovastatin
Breast Cancer
Washington University School of MedicineP2CC (40)
mdx2001
Breast Cancer
ModeX Therapeutics, An OPKO Health CompanyP1/2CC (40)
Mirdametinib
Breast Cancer
Memorial Sloan Kettering Cancer CenterP1/2CC (40)
mt-4561
Breast Cancer
Tanabe Pharma America, Inc.P1/2CC (40)
ngm707
Breast Cancer
NGM Biopharmaceuticals, IncP1/2CC (40)
Palacaparib
Breast Cancer
AstraZenecaP1/2CC (40)
Showing 551 to 600 of 849 assets
PreviousPage 12 of 17Next